- Home
- ZVIA vs CVRX Comparison
ZVIA vs CVRX Comparison
Compare ZVIA & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVIA
- CVRX
- Stock Information
- Founded
- ZVIA 2007
- CVRX 2000
- Country
- ZVIA United States
- CVRX United States
- Employees
- ZVIA N/A
- CVRX N/A
- Industry
- ZVIA Beverages (Production/Distribution)
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ZVIA Consumer Staples
- CVRX Health Care
- Exchange
- ZVIA Nasdaq
- CVRX Nasdaq
- Market Cap
- ZVIA 193.4M
- CVRX 203.9M
- IPO Year
- ZVIA 2021
- CVRX 2021
- Fundamental
- Price
- ZVIA $2.66
- CVRX $9.96
- Analyst Decision
- ZVIA Buy
- CVRX Buy
- Analyst Count
- ZVIA 5
- CVRX 7
- Target Price
- ZVIA $4.89
- CVRX $13.17
- AVG Volume (30 Days)
- ZVIA 779.4K
- CVRX 213.8K
- Earning Date
- ZVIA 11-05-2025
- CVRX 11-05-2025
- Dividend Yield
- ZVIA N/A
- CVRX N/A
- EPS Growth
- ZVIA N/A
- CVRX N/A
- EPS
- ZVIA N/A
- CVRX N/A
- Revenue
- ZVIA $162,849,000.00
- CVRX $55,969,000.00
- Revenue This Year
- ZVIA $6.44
- CVRX $11.32
- Revenue Next Year
- ZVIA $6.68
- CVRX $18.58
- P/E Ratio
- ZVIA N/A
- CVRX N/A
- Revenue Growth
- ZVIA 6.17
- CVRX 18.44
- 52 Week Low
- ZVIA $0.96
- CVRX $4.30
- 52 Week High
- ZVIA $4.99
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- ZVIA 54.07
- CVRX 57.01
- Support Level
- ZVIA $2.29
- CVRX $10.10
- Resistance Level
- ZVIA $2.42
- CVRX $11.30
- Average True Range (ATR)
- ZVIA 0.12
- CVRX 0.57
- MACD
- ZVIA 0.02
- CVRX -0.12
- Stochastic Oscillator
- ZVIA 52.50
- CVRX 34.87
About ZVIA Zevia PBC
Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.